Tom Clement, the CEO of Pathway Medical, has been named the new chairman of the Washington Biotechnology and Biomedical Association. He’s been busy lately at his day job, since Pathway, a Kirkland, WA-based maker of medical devices to clear fatty buildups in leg arteries, won FDA approval of its first device. Clement’s term with the WBBA last two years. He takes over for Jim Gore of the Pacific Northwest Diabetes Research Center.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
